Development and Validation of a RP- HPLC Method for Simultaneous Estimation of Rosiglitazone and Metformin in Bulk and Tablet Dosage Form
 
More details
Hide details
1
School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
2
Shri Gopichand College of Pharmacy, Baghpat, Uttar Pradesh, India
CORRESPONDING AUTHOR
Dhirender Singh Mittan   

School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
Publish date: 2017-11-01
 
Eurasian J Anal Chem 2011;6(3):189–196
KEYWORDS
ABSTRACT
A simple reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for simultaneous determination of rosiglitazone and metformin in bulk and tablet dosage form. Chromatographic analysis was performed on a C18 column (250x 4.6 mm, 5μm) with a mixture of Ammonium dihydrogen Phosphate buffer (pH 4.5): Acetonitrilein in the ratio 65:35 as mobile phase, at a flow rate of 1.0 mL min-1. UV detection was performed at 230 nm. The method was validated for accuracy, precision, specificity, linearity and sensitivity. The retention times of rosiglitazone and metformin were 7.19±0.044 and 5.57±0.038 min, respectively. Calibration plots were linear over the concentration ranges 12–32 μg mL-1 and 20–70 μg mL-1 for rosiglitazone and metformin, respectively. The Limit of detection was 1.100 and 0.712 μg mL-1 and the quantification limit was 3.66 μg mL-1 and 2.41 μg mL-1 for metformin and rosiglitazone, respectively. The accuracy of the proposed method was determined by recovery studies and found to be 97.72% to 100.46%. Commercial tablet formulation was successfully analyzed using the developed method and the proposed method is applicable to routine analysis of determination of rosiglitazone and metformin in bulk and tablet dosage form.
 
REFERENCES (9)
1.
Gomes P, Sippel J, Jabionski A, Steppe M (2004) Determination of rosiglitazone in coated tablets by MEKC and HPLC methods. J Pharm Biomed Anal.36 (4): 909-913.
 
2.
Radhakrishan T, Satyanaryana J, Satyanaryana A (2002) LC determination of rosiglitazone in bulk and pharmaceutical formulation. J Pharm Biomed Anal.29(5): 873-880.
 
3.
Rao N V S M, Biju B, Mullangi R, Nuggehally R S (2003) Simple method for the determination of rosiglitazone in human plasma using commercially available internal standard. J Biomed Chrom.17: 417-420.
 
4.
Jahanvi N J, Sadhna J R, Bhavesh D, Shivprakash R (2008) Development and validation Of LC-UV for simultaneous estimation of rosigliazone and glimepiride in human plasma.67(11/12)):951-955.
 
5.
Kolte B L,Raut BB,Deo AA,Bagool MA, Shinde DB(2004) Simultaneous Estimation of metformin in combination with rosiglitazone by RP-HPLC. J Chrom Science.42: 70-73.
 
6.
Zarghi A, Foroutan S M, Shafaati A, Khoddam A (2003) Rapiddetermination of metformin in human plasma using ion-pair HPLC. J Pharm Biomed Anal 31:197-200.
 
7.
Rathinavel R, Umanath U, Valarmathy J, Samueljoshua L, Ganesh M, Shivkumar T, Priyadarshan R (2009) RP-HPLC Method for the SimultaneousEstimation of Rosiglitazone and Gliclazide in Tablets. E J Chem 6(4):1188-1192.
 
8.
Kang X, Wang F, Xie Z, Li H (2009) A high performance liquid chromatography method for simultaneous determination of rosiglitazone and gemfibrozil in human plasma. J Chrom B.877: 645-648.
 
9.
International Conference on Harmonization (ICH), Validation of Analytical Procedures: Text and Methodology Q2 (R1), November.
 
eISSN:1306-3057